Catalyst Wire Dossier Catalyst Wire Dossier

ARRY-380

· Array Biopharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARRY-380, covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: ARRY-380 + Trastuzuamab for Breast w/ Brain Mets [Phase 1]

See pricing